Table 1.
Clinical and laboratory parameters of the study population
| Parameters | Mean ± SD | Range |
|---|---|---|
| Age (years) | 48.9 ± 15.1 | 17–81 |
| Gender (male/female), n/n | 133/90 | – |
| Diabetes, n (%) | 38 (17.0) | – |
| CVD, n (%) | 57 (30.8) | – |
| HD vintage (months) | 106 ± 72 | 3–311 |
| BMI (kg/m2) | 24.0 ± 4.3 | 16.2–45.8 |
| SBP (mmHg) | 136 ± 23 | 84–198 |
| DBP (mmHg) | 81 ± 15 | 40–120 |
| PP (mmHg) | 55 ± 15 | 24–106 |
| Hemoglobin (g/L) | 106.9 ± 12.7 | 62–138 |
| Single-pool Kt/V | 1.24 ± 0.21 | 0.71–1.76 |
| Follow-up UA (µmol/L) | 425 ± 59 | 294–620 |
| Urea (mmol/L) | 29.2 ± 3.6 | 17.8–39 |
| Creatinine (µmol/L) | 919.9 ± 203.9 | 450–1670 |
| Albumin (g/L) | 38.5 ± 3.2 | 26.7–46.9 |
| PCR (g/kg/day) | 1.03 ± 0.14 | 0.58–1.43 |
| iPTH (pg/mL) | 216.5 ± 231.1 | 15–1670 |
| HDL cholesterol (mmol/L) | 0.99 ± .27 | 0.4–1.80 |
| LDL cholesterol (mmol/L) | 2.66 ± 0.87 | 1.2–7.8 |
| Calcium (mmol/L) | 2.29 ± 0.14 | 1.89–2.71 |
| Phosphorus (mmol/L) | 1.50 ± 0.34 | 0.63–2.7 |
| Potassium (mmol/L) | 5.99 ± 0.60 | 4.4–8.0 |
| BNP (pg/mL) | 1321 ± 1366 | 109.7–8237.6 |
| LVMI (g/m2) | 138.4 ± 49.7 | 54–438 |
| CRP (mg/L) | 15.9 ± 23.8 | 0.35–117 |
iPTH, intact parathyroid hormone.